Few saida sentiment echoed by many of his colleagues: Only the future will tell. Thank you to all of the doctors who shared insights into what they're noticing in their own patients who are taking, or have taken, GLP-1s for weight loss: Jason Diamond, MD, FACS, a double board-certified facial plastic surgeon in Beverly Hills
Oncology (Williston Park) 25 , 378
Cost-effectiveness questionable for osteoporosis alone versus established treatments though valuable if seeking multiple peptide benefits (body composition, recovery, general health)
10.1093/humrep/deab130.287 119 TocciV.MirabelliM.SalatinoA.SiciliaL.GiulianoS.BrunettiF
Abstract Background The SUSTAIN 6 trial demonstrated that once-weekly semaglutide (0.5 and 1.0 mg) significantly reduced major adverse cardiovascular (CV) events (MACE) vs placebo in subjects with type 2 diabetes (T2D) and high CV risk